Trial Profile
Collagenase Clostridium Histolytic is a Common Treatment of MCP and PIP Joint Contractures in Dupuytren Disease. A 1 to 4 Year Followup Study of 198 Joints
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Apr 2020
Price :
$35
*
At a glance
- Drugs Collagenase clostridium histolyticum (Primary)
- Indications Dupuytren's contracture
- Focus Therapeutic Use
- 20 Apr 2020 Status changed from active, no longer recruiting to completed.
- 09 Nov 2017 New trial record